Oscar Badillo

Forskare vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Mats Hellström

E-post:: oscar.badillo@igp.uu.se
Besöksadress:: Dag Hammarskjölds väg 20
751 85 Uppsala
Postadress:: Rudbecklaboratoriet
751 85 UPPSALA

Ladda ned kontaktuppgifter för Oscar Badillo vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Mats Hellström

Publikationer

Senaste publikationer

Alla publikationer

Artiklar i tidskrift

Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatment

Badillo-Godinez, Oscar; Niemi, Jenni; Helfridsson, Liam; Karimi, Shokoufeh et al.

Ingår i Journal for ImmunoTherapy of Cancer, 2025
- DOI för Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatment
- Ladda ner fulltext (pdf) av Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatment
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Simonds, Erin F.; Lu, Edbert D.; Badillo, Oscar; Karimi, Shokoufeh et al.

Ingår i Journal for ImmunoTherapy of Cancer, 2021
- DOI för Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma
- Ladda ner fulltext (pdf) av Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Artiklar, forskningsöversikt

Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells

Badillo, Oscar; Helfridsson, Liam; Niemi, Jenni; Hellström, Mats

Ingår i Upsala Journal of Medical Sciences, 2024
- DOI för Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells
- Ladda ner fulltext (pdf) av Exploring dendritic cell subtypes in cancer immunotherapy: unraveling the role of mature regulatory dendritic cells